The remarkable commercial success of GLP-1 receptor agonists is fueling investment, accelerating science, and creating new analytical challenges. Here, we outline the hurdles these peptides present, explore methods for impurity profiling and structural characterization, and consider strategies to keep pace with this fast-moving field.
12
min read
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.